A phase I clinical trial to investigate the safety and efficacy of two candidate Mycobacterium avium subspecies paratuberculosis (MAP) vaccines in patients with active Crohn's disease

2020 ◽  
Author(s):  
Michael Stallibrass
Keyword(s):  
Clinical Trial ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase I ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Subspecies Paratuberculosis ◽  
Phase I Clinical Trial ◽  
Safety And Efficacy

Oral immune regulation using colitis extracted proteinsȁA new model of treatment of Crohn's disease: Results of a phase I clinical trial

2003 ◽  
Vol 124 (4) ◽  
pp. A518 ◽  
Author(s):  
Eran Israeli ◽  
Eran Goldin ◽  
Nilla Hemed ◽  
Barbara Thalenfeld ◽  
Dean Engelhardt ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase I ◽  
Immune Regulation ◽  
Phase I Clinical Trial ◽  
New Model

scholarly journals Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease

2012 ◽  
Vol 20 (4) ◽  
pp. 870-876 ◽  
Author(s):  
Giovanni Monteleone ◽  
Massimo C Fantini ◽  
Sara Onali ◽  
Francesca Zorzi ◽  
Giulia Sancesario ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase I ◽  
Antisense Oligonucleotide ◽  
Phase I Clinical Trial

scholarly journals Molecular identification of Mycobacterium avium subspecies paratuberculosis in oral biopsies of Crohn’s disease patients

Gut Pathogens ◽  
2013 ◽  
Vol 5 (1) ◽  
pp. 18 ◽  
Author(s):  
Paola Molicotti ◽  
Antonio M Scanu ◽  
Aurea Lumbau ◽  
Sara Cannas ◽  
Alessandra Bua ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Molecular Identification ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Subspecies Paratuberculosis
Sign in / Sign up

Export Citation Format

Share Document